» Authors » Aisling Barry

Aisling Barry

Explore the profile of Aisling Barry including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 431
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
OReilly S, Lynch E, Hwang E, Brown M, ODonovan T, Hennessy M, et al.
Clin Breast Cancer . 2024 Dec; PMID: 39668009
Climate change is the greatest threat to human existence. Currently it impacts breast cancer care by disrupting treatment, by food poverty and economic hardship and through fossil fuel pollution which...
2.
Navarro-Domenech I, Barry A, Tsai J, Ma G, Wong P
Cureus . 2024 Nov; 16(10):e72500. PMID: 39600746
Materials And Methods:  This is a quality improvement (QI) study conducted via an anonymous survey. Three different clinical scenarios of OMD (oligo-recurrence disease, synchronous de-novo OMD, and oligo-progressive disease) were...
3.
Glicksman R, Raman S, Ye X, Bedard P, Bratman S, Chen E, et al.
Int J Radiat Oncol Biol Phys . 2024 Sep; 121(2):292-306. PMID: 39270828
Purpose: In oligoprogressive (OP) cancer, there are a limited number of metastatic areas progressing on a background of stable or responding to widespread cancer. Although the standard of care for...
4.
Tan V, Padayachee J, Rodrigues G, Navarro I, Shah P, Palma D, et al.
Radiother Oncol . 2024 Aug; 200:110505. PMID: 39197501
Introduction: The aim of this systematic review and meta-analysis was to review evidence and pool outcomes to assess the effectiveness of stereotactic ablative radiotherapy (SABR) in patients treated for oligoprogressive...
5.
Semeniuk O, Shessel A, Velec M, Fodor T, Rocca C, Barry A, et al.
Phys Med Biol . 2024 Jul; 69(16). PMID: 39048106
To develop and validate a dose-of-the-day (DOTD) treatment plan verification procedure for liver and pancreas cancer patients treated with an magnetic resonance (MR)-Linac system.DOTD was implemented as an automated process...
6.
Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, et al.
BMC Cancer . 2024 Feb; 24(1):171. PMID: 38310262
Background: Radiotherapy delivery regimens can vary between a single fraction (SF) and multiple fractions (MF) given daily for up to several weeks depending on the location of the cancer or...
7.
Yanagihara T, Tepper J, Moon A, Barry A, Molla M, Seong J, et al.
Pract Radiat Oncol . 2024 Jan; 14(2):134-145. PMID: 38244026
Purpose: External beam radiation therapy (EBRT) is a highly effective treatment in select patients with hepatocellular carcinoma (HCC). However, the Barcelona Clinic Liver Cancer system does not recommend the use...
8.
Riad A, Barry A, Knight S, Arbaugh C, Haque P, Weiser T, et al.
J Glob Health . 2023 Oct; 13:04114. PMID: 37787105
Background: Enhanced recovery after surgery (ERAS) protocols have largely been incorporated into practice in high-income settings due to proven improvement in perioperative outcomes. We aimed to review the implementation of...
9.
Mushonga M, Helou J, Weiss J, Dawson L, Wong R, Hosni A, et al.
Cancers (Basel) . 2023 Jun; 15(10). PMID: 37345175
Purpose: To retrospectively review the clinical outcomes of patients with metastatic breast cancer (MBCa) following liver directed ablative intent radiotherapy (RT). Methods: Demographics, disease and treatment characteristics of patients with...
10.
Weadick C, Keogh R, Carroll H, Boldrin S, Mulroe E, Murphy L, et al.
J Cancer Policy . 2023 Feb; 35:100410. PMID: 36773799
In recent years the terms time and financial toxicities have entered the vocabulary of cancer care. We would like to introduce another toxicity: climate toxicity. Climate toxicity is a double-edge...